RAD51 Expression as a Biomarker to Predict Efficacy of Preoperative Therapy and Survival for Esophageal Squamous Cell Carcinoma: A Large-cohort Observational Study (KSCC1307)

OBJECTIVE:The aim of this study is to identify biomarkers that predict efficacy of preoperative therapy and survival for esophageal squamous cell carcinoma (ESCC). BACKGROUND:It is essential to improve the accuracy of preoperative molecular diagnostics to identify specific patients who will benefit...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Annals of surgery 2022-04, Vol.275 (4), p.692-699
Hauptverfasser:	Saeki, Hiroshi, Jogo, Tomoko, Kawazoe, Tetsuro, Kamori, Tomohiro, Nakaji, Yu, Zaitsu, Yoko, Fujiwara, Minako, Baba, Yoshifumi, Nakamura, Tetsu, Iwata, Naoki, Egashira, Akinori, Nakanoko, Tomonori, Morita, Masaru, Tanaka, Yoshihiro, Kimura, Yasue, Shibata, Tomotaka, Nakashima, Yuichiro, Emi, Yasunori, Makiyama, Akitaka, Oki, Eiji, Tokunaga, Shoji, Shimokawa, Mototsugu, Mori, Masaki
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biomarkers Carcinoma, Squamous Cell - surgery Chemoradiotherapy Cisplatin - therapeutic use Docetaxel - therapeutic use Esophageal Neoplasms Esophageal Squamous Cell Carcinoma - therapy Fluorouracil - therapeutic use Humans Prognosis Rad51 Recombinase - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!